Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993
For visual reference only; actual product may vary
For visual reference only; actual product may vary
Aimovig (Erenumab) is a prescription once-monthly injection for the preventive treatment of migraine in adults. It works by blocking the CGRP receptor pathway, a key contributor to migraine attacks. This innovative treatment can significantly reduce the number of monthly migraine days, offering new hope for migraine sufferers.
| Aimovig Brand | 70mg 1 Pre-Filled Pen |
-
|
Our price: $635.00 |
|
| Aimovig Brand | 140mg 1 Pre-Filled Pen |
-
|
Our price: $623.00 |
Aimovig is a prescription medication used for the preventive treatment of migraine in adults. Unlike acute treatments that relieve migraine symptoms once they start, Aimovig is taken on a regular schedule to reduce the number of migraine days you experience each month. The active ingredient, erenumab, is a human monoclonal antibody, which represents a modern, targeted approach to migraine prevention. It is not a narcotic or an opiate and is not considered addictive. Aimovig is administered as a once-monthly subcutaneous injection, making it a convenient option for long-term migraine management.
Aimovig works by targeting and blocking the calcitonin gene-related peptide (CGRP) receptor. CGRP is a protein naturally found in your nervous system that plays a critical role in the process of a migraine attack. When CGRP levels increase, it can cause intense inflammation and pain by making blood vessels in the brain dilate. Aimovig, as a monoclonal antibody, is designed to specifically identify and attach to the CGRP receptor. By blocking this receptor, Aimovig prevents CGRP from binding to it, thereby inhibiting its ability to trigger the cascade of events that lead to a migraine attack, ultimately reducing their frequency.
Aimovig is intended for adults who suffer from either episodic or chronic migraines. It is prescribed as a preventive therapy for patients who experience four or more migraine days per month and are seeking to reduce that frequency. Aimovig can be a suitable option for individuals who have not had success with other preventive migraine medications or who have found the side effects of older treatments, like oral medications, difficult to tolerate. Because it is a targeted therapy with a different mechanism of action, it offers a valuable alternative for managing this debilitating condition.
Aimovig is administered as a subcutaneous (under the skin) injection once every month. It comes in a pre-filled autoinjector pen designed for easy self-administration at home. The recommended starting dose is typically 70 mg, though a 140 mg dose is also available if your doctor determines it is necessary. Your healthcare provider will show you how to properly use the autoinjector. Common injection sites include the thigh, abdomen, or the back of the upper arm. It is important to rotate injection sites and follow the prescribed dosage exactly as directed by your doctor.
The most common side effects associated with Aimovig are generally mild and manageable. These primarily include reactions at the injection site, such as pain, redness, or swelling. Constipation is another frequently reported side effect and can occasionally be severe. Other less common effects may include muscle cramps or spasms. Serious allergic reactions are rare but possible; seek immediate medical help if you experience symptoms like rash, hives, trouble breathing, or swelling of the face, tongue, or throat. Always discuss any side effects you experience with your healthcare provider.
Choosing IsraelPharm for your Aimovig prescription provides a reliable and cost-effective solution for your migraine management. We source our medications from a highly regulated and secure supply chain, ensuring you receive authentic, high-quality products. Our competitive pricing on brand-name medications like Aimovig makes long-term treatment more affordable. With a straightforward ordering process and a dedicated customer service team, we make accessing your essential medications simple and convenient, delivering them directly to your door. Trust IsraelPharm for a professional and seamless pharmacy experience.
Most side effects of Aimovig are mild to moderate. Consult your doctor if you experience any of these symptoms persistently. Common side effects include:
Severe side effects are rare but can occur. Seek immediate medical attention if you experience signs of a serious allergic reaction, such as swelling of the face, mouth, tongue, or throat, or trouble breathing. Severe constipation with serious complications can also occur.
Aimovig is indicated for the preventive treatment of migraine in adults.
Some patients may start to see a reduction in their monthly migraine days within the first month of treatment. However, for others, it may take up to three months to experience the full preventive benefits of the medication. It's important to continue with the monthly injections as prescribed by your doctor to properly evaluate its effectiveness for you. Tracking your migraine days can help you and your doctor assess the results.
If you miss a dose of Aimovig, you should administer it as soon as you remember. After you take the missed dose, your next dose should be scheduled one month from that date to get back on a regular monthly schedule. Do not take two doses at once to make up for a missed one. If you are unsure what to do, contact your doctor or pharmacist for guidance.
It is not known if Aimovig is safe to use during pregnancy or while breastfeeding, so it is generally not recommended. There is limited data on its effects on an unborn baby or its presence in breast milk. If you are pregnant, planning to become pregnant, or breastfeeding, you must discuss the potential risks and benefits with your doctor to make an informed decision about your migraine treatment.
Aimovig should be stored in the refrigerator between 36°F to 46°F (2°C to 8°C) in its original carton to protect it from light. Do not freeze or shake the pen. Before injection, you can leave it at room temperature for at least 30 minutes. If necessary, it can be kept at room temperature (up to 77°F/25°C) for up to 7 days, but it should not be put back in the refrigerator after that period.
Aimovig has a low risk of interacting with other drugs because it is a monoclonal antibody that is processed differently in the body than most oral medications. It is not metabolized by the liver's cytochrome P450 enzymes. However, it is still crucial to inform your doctor about all prescription drugs, over-the-counter medicines, and supplements you are taking to ensure your overall treatment plan is safe and effective.
No, Aimovig is not a cure for migraines. It is a preventive (prophylactic) treatment designed to reduce the number of migraine days a person experiences each month. While many patients find significant relief and a better quality of life while using Aimovig, it does not eliminate migraines entirely. You may still experience occasional migraine attacks that require acute or 'rescue' medication.
No, Aimovig is not a 'rescue' medication and will not stop a migraine attack that has already started. It is a preventive treatment that works over time to reduce the frequency of future attacks. You should have a separate acute treatment, as prescribed by your doctor, to manage the pain and symptoms of a migraine attack when it occurs.
If you stop taking Aimovig, its preventive effects will gradually wear off. It is likely that the frequency of your migraine attacks will return to the level they were at before you started the treatment. Aimovig does not cause withdrawal symptoms, but the underlying condition will no longer be managed by the medication. Any decision to stop treatment should be discussed with your healthcare provider.
There are no specific dietary or alcohol restrictions directly associated with the use of Aimovig itself. The medication does not interact with food or alcohol. However, many people find that certain foods or alcoholic beverages can act as triggers for their migraines. It is wise to continue avoiding any known personal triggers while using Aimovig to achieve the best results from your preventive therapy.
Your healthcare provider will teach you how to properly inject Aimovig using the prefilled autoinjector. You will self-administer the injection under the skin (subcutaneously) of your thigh, abdomen, or the back of your upper arm. The process involves cleaning the site, placing the pen on your skin, and pushing the button to deliver the dose. It's designed to be simple for patients to use at home.
Weight gain was not reported as a common side effect during the clinical trials for Aimovig. Unlike some other classes of preventive migraine medications, which can be associated with changes in weight, CGRP inhibitors like Aimovig are generally considered to be weight-neutral. If you experience any unusual changes in your weight while taking the medication, you should discuss it with your doctor.
Yes, you can travel with your Aimovig pen. It should be transported in its original carton and can be kept at room temperature (up to 77°F/25°C) for a maximum of 7 days. If your trip is longer, you will need a cooler with ice packs to keep it refrigerated. Be sure to check airline regulations for carrying medications and never place it in checked luggage.
Aimovig is available in two monthly doses: 70 mg and 140 mg. The standard starting dose is 70 mg. If you and your doctor find that this dose is not providing a sufficient reduction in your migraine days, your doctor may decide to increase the prescription to the 140 mg dose. The higher dose is administered as two separate 70 mg injections, one right after the other.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days
IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.
Learn how biologic medications like Stelara and Prolia treat chronic conditions by targeting specific parts of the immune system and bone cells.
For so many women, their own health takes a back seat – not because they ignore it, but rather because life is loud. Work, family, caregiving, aging parents, hormones, sleep, stress. Life is like a
Despite years of research and real-world use, there is still no FDA-approved testosterone therapy designed specifically for women. Now, that gap is getting renewed attention. Discussion around testosterone therapy for women has shifted in recent
